MEI Pharma, Inc.
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Governance
- Compliance
- Ethical Conduct
Governance Achievements
- Established a Code of Business Conduct and Ethics
- Designated the Audit Committee to review related party transactions
- Designated the Nominating and Governance Committee to oversee the Code
- Established reporting procedures for conflicts of interest and related party transactions
Climate Goals & Targets
Environmental Challenges
- Potential conflicts of interest
- Insider trading
- Foreign Corrupt Practices Act (FCPA) compliance
- Maintaining a drug-free workplace
- Preventing harassment and discrimination
- Ensuring environmental compliance
- Maintaining health and safety standards
Mitigation Strategies
- Established clear guidelines and reporting procedures to address conflicts of interest
- Implemented policies to prevent insider trading
- Required full compliance with the FCPA
- Established policies regarding alcohol and drug use
- Prohibited harassment and discrimination
- Required compliance with environmental laws
- Implemented health and safety policies